Business Wire

PUMA Concludes Season One of Industry-first Sustainability Report Podcast Series

Share

The final episode of PUMA’s RE:GEN REPORTS is now available to stream: ‘When it comes to Health and Safety, does the West know best?’. In this episode, hosted by the Head of Knowledge Exchange at the Centre for Sustainable Fashion, Monica Buchan-Ng, PUMA’s Chief Sourcing Officer, Anne-Laure Descours, reminds audiences that it’s important for people in the North to “recognize how much people on the ground are trying to improve [factory working conditions].

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230801314932/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The final episode of PUMA’s RE:GEN REPORTS is now available to stream: ‘When it comes to Health and Safety, does the West know best?’. (Photo: Business Wire)

The podcast series aims to make PUMA’s 2022 Sustainability Report more accessible to a wider and younger audience. This came after research conducted last year which found that young people want brands to be more transparent with consumers when it comes to the environment and sustainability (34%) and to communicate their goals better (40%).

In 2022 PUMA hosted Conference of the People, where Gen Z representatives, PUMA’s industry peers, activists, NGOs, experts, ambassadors, and consumers met to discuss some of the fashion industry’s sustainability challenges. The conference also highlighted the need for PUMA to improve on how it was communicating sustainability goals, actions, and progress.

RE:GEN REPORTS is hosted by 10 next-generation thinkers from six countries, distilling the content of the brand’s sustainability report into 10 episodes. Each host was tasked with breaking down the complex topics into digestible pieces. Focusing on PUMA’s sustainability strategy FOREVER.BETTER. 10FOR25 sustainability targets, the podcasts were created to eliminate barriers of traditional sustainability language, explaining why the specific targets were a focus for the business. Episodes discuss progress that has been made, whilst acknowledging areas where there is still work to be done.

From a 147-page report and over thirty hours of recording came this 163-minute series of clear and relatable sustainability information. As well as the final episode on health and safety, young people guided audiences through episodes about: human rights, hosted by Award-winning activist, model, and social entrepreneur Anya Dillard from the USA; chemicals, hosted by sustainable and healthy living vlogger Luke Jaque-Rodney from Germany; circularity, hosted by USA-based upcycler Andrew Burgess; fair wages, hosted by Fair Labor Association student committee member Amina Shakeel; climate action, hosted by Earthero Project co-founder Bertha Shum from Hong Kong; biodiversity hosted by India-based environmental activist Ripudaman Bevli; plastic & oceans, hosted by Singapore sustainable bag company Peco Bag founder Yumika Hoskin; product, hosted by intersectional environmentalist Diandra Marizet from the US and water and air, hosted by Malaysian based eco-conscious Earth Day Ambassador Melissa Tan .

As well as PUMA spokespeople, the young hosts also interviewed representatives from industry bodies, businesses, and NGOs in discussions around the implementation and monitoring of more sustainable practices. Guests included Fair Labor Association’s Chief of Staff, Shelly Han; UNFCCC’s Sector’s Engagement in Climate Action Lead, Lindita Xhaferi-Salihu; Canopy’s Founder and Executive Director, Nicole Rycroft; ZDHC Implementation Director, Klass Nuttbohm; Apparel Impact Institute’s Chief Impact Officer, Kurt Kipka; and Leather Working Group’s Traceability Manager, Vanessa Brain.

“Transparency is critical to our sustainability strategy at PUMA,” says Anne-Laure Descours, Chief Sourcing Officer at PUMA. “We are committed to improving our practices and equally acknowledging where there is still a way for us to go. We invited these next generation thinkers to interview us and our partners on our FOREVER.BETTER. sustainability strategy 10FOR25 targets to push us to be better, to do better, and get into the detail in a way that more people can access and understand. It’s easy to hide areas where you’re not making progress as quickly as you’d like, but change requires collaboration and openness and with RE:GEN REPORTS we have and will continue to welcome both of those things.”

PUMA’s sustainability efforts have been recognized several times. In 2022, the brand topped the Business of Fashion sustainability ranking, the platform on living wage financials ranking, and the FTSE4Good ranking within its sectors. It was included in the Corporate Knights global top 100 most sustainable companies ranking, maintained its triple-A ranking with MSCI and its prime status with ISS; two leading sustainability rating agencies. Reuters also ranked it as number two within its sector and, in S&P sustainability benchmarking, PUMA outperformed all other sports brands for the first time since 2010. Although these rankings help confirm that PUMA is headed in the right direction with its FOREVER.BETTER. sustainability strategy, the brand recognizes that it still has a long way to go.

PUMA’s full 2022 Sustainability Report can be accessed here.

PUMA

PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Samantha Du Plessis - PUMA SE
Samantha.duplessis@puma.com

Lornette Harley – MSL
lornette.harley@mslgroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye